Targeting Nrf2-mediated gene transcription by triterpenoids and their derivatives

Biomolecules and Therapeutics

Volumn 20, Issue 6, 2012, Pages 499-505

  Loboda, Agnieszka ^a   Rojczyk Golebiewska, Ewa ^a   Bednarczyk Cwynar, Barbara ^b   Zaprutko, Lucjusz ^b   Jozkowicz, Alicja ^a   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anti oxidant response; Betulin; Chemoprevention; Oleanolic acid; Triterpenoids

Indexed keywords

BARDOXOLONE; BARDOXOLONE IMIDAZOLIDE; BARDOXOLONE METHYL; CISPLATIN; ERYTHRODIOL; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MICRORNA; OLEANANE; OLEANOLATE A HOMO LACTAM; OLEANOLIC ACID; PARACETAMOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SUCCINIMIDE; TRANSCRIPTION FACTOR NRF2; TRITERPENOID; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; ARTICLE; BIOINFORMATICS; CELL PROTECTION; CHEMOPROPHYLAXIS; DIABETES MELLITUS; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PAPILLOMA; PAW EDEMA; PROTEIN EXPRESSION; TREATMENT RESPONSE;

EID: 84870892036     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.6.499     Document Type: Article

References (58)

1. Ahmad, R., Raina, D., Meyer, C., Kharbanda, S. and Kufe, D. (2006) Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179. J. Biol. Chem. 281, 35764-35769.
2. Aleksunes, L. M., Goedken, M. J., Rockwell, C. E., Thomale, J., Manautou, J. E. and Klaassen, C. D. (2010) Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J. Pharmacol. Exp. Ther. 335, 2-12.
3. Begum, S., Sultana, I., Siddiqui, B. S., Shaheen, F. and Gilani, A. H. (2002) Structure and spasmolytic activity of eucalyptanoic acid from Eucalyptus camaldulensis var. obtusa and synthesis of its active derivative from oleanolic acid. J. Nat. Prod. 65, 1939-1941.
4. Bloom, D. A. and Jaiswal A. K. (2003) Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278, 44675-44682.
5. Chintharlapalli, S., Papineni, S., Abdelrahim, M., Abudayyeh, A., Jutooru, I., Chadalapaka, G., Wu, F., Mertens-Talcott, S., Vanderlaag, K., Cho, S. D., Smith, R. 3rd and Safe, S. (2009) Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int. J. Cancer. 125, 1965-1974.
6. Chintharlapalli, S., Papineni, S., Lei, P., Pathi, S. and Safe, S. (2011) Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11, 371.
7. Ciesla, M., Skrzypek, K., Kozakowska, M., Loboda, A., Jozkowicz, A. and Dulak, J. (2011) MicroRNAs as biomarkers of disease onset. Anal. Bioanal. Chem. 401, 2051-2061.
8. Deeb, D., Gao, X., Jiang, H., Janic, B., Arbab, A. S., Rojanasakul, Y., Dulchavsky, S. A. and Gautam, S. C. (2010) Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. Biochem. Pharmacol. 79, 350-360.
9. Deeb, D., Gao, X., Liu, Y., Jiang, D., Divine, G. W., Arbab, A. S., Dulchavsky, S. A. and Gautam, S. C. (2011) Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Carcinogenesis 32, 757-764.
10. Fujiwara, Y., Komohara, Y., Kudo, R., Tsurushima, K., Ohnishi, K., Ikeda, T. and Takeya, M. (2011) Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncol. Rep. 26, 1533-1537.
11. Gao, X., Deeb, D., Hao, J., Liu, Y., Arbab, A. S., Dulchavsky, S. A. and Gautam, S. C. (2010) Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa} B signaling proteins in colorectal cancer cells. Anticancer Res. 30, 785-792.
12. Gao, X., Liu, Y., Deeb, D., Arbab, A. S., Guo, A. M., Dulchavsky, S. A. and Gautam, S. C. (2011) Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-kappaB/mTOR signaling. Anticancer Res. 31, 3673-3681.
13. Giudice, A., Arra, C. and Turco, M. C. (2010) Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol. Biol. 647, 37-74.
14. Gupta, M. B., Bhalla, T. N., Gupta, G. P., Mitra, C. R. and Bhargava, K. P. (1969) Anti-inflammatory activity of natural products. I. Triterpenoids. Eur. J. Pharmacol. 6, 67-70.
15. Huang, H. C., Nguyen, T. and Pickett, C. B. (2002) Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277, 42769-42774.
16. Jutooru, I., Chadalapaka, G., Abdelrahim, M., Basha, M. R., Samudio, I., Konopleva, M., Andreeff, M. and Safe, S. (2010) Methyl 2-cyano3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Mol. Pharmacol. 78, 226-236.
17. Kaidery, N. A., Banerjee, R., Yang, L., Smirnova, N. A., Hushpulian, D. M., Liby, K. T., Williams, C. R., Yamamoto, M., Kensler, T. W., Ratan, R. R., Sporn, M. B., Beal, M. F., Gazaryan, I. G. and Thomas, B. (2012) Targeting Nrf2-Mediated Gene Transcription by Extremely Potent Synthetic Triterpenoids Attenuate Dopaminergic Neurotoxicity in the MPTP Mouse Model of Parkinson's Disease. Antioxid. Redox Signal. Epub ahead of print.
18. Karius, T., Schnekenburger, M., Dicato, M. and Diederich, M. (2012) MicroRNAs in cancer management and their modulation by dietary agents. Biochem. Pharmacol. 83, 1591-1601.
19. Kwak, M. K. and Kensler, T. W. (2010) Targeting NRF2 signaling for cancer chemoprevention. Toxicol. Appl. Pharmacol. 244, 66-76.
20. Li, W. and Kong, A. N. (2009) Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48, 91-104.
21. Li, Y., Kong, D., Wang, Z. and Sarkar, F. H. (2010) Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res. 27, 1027-1041.
22. Liby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., Gribble, G. W., Hill-Kapturczak, N., Agarwal, A. and Sporn, M. B. (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65, 4789-4798.
23. Liby, K., Risingsong, R., Royce, D. B., Williams, C. R., Yore, M. M., Honda, T., Gribble, G. W., Lamph, W. W., Vannini, N., Sogno, I., Albini, A. and Sporn, M. B. (2008) Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268. Clin. Cancer Res. 14, 4556-4563.
24. Liby, K., Royce, D. B., Williams, C. R., Risingsong, R., Yore, M. M., Honda, T., Gribble, G. W., Dmitrovsky, E., Sporn, T. A. and Sporn, M. B. (2007a) The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res. 67, 2414-2419.
25. Liby, K. T., Royce, D. B., Risingsong, R., Williams, C. R., Maitra, A., Hruban, R. H. and Sporn, M. B. (2010) Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. Cancer Prev. Res. (Phila) 3, 1427-1434.
26. Liby, K. T., Yore, M. M. and Sporn, M. B. (2007b) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 7, 357-369.
27. Liu, J., Liu, Y., Mao, Q. and Klaassen, C. D. (1994) The effects of 10 triterpenoid compounds on experimental liver injury in mice. Fundam. Appl. Toxicol. 22, 34-40.
28. Liu, J., Wu, Q., Lu, Y. F. and Pi, J. (2008) New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction. Biochem. Pharmacol. 76, 922-928
29. Liu, X., Jutooru, I., Lei, P., Kim, K., Lee, S. O., Brents, L. K., Prather, P. L. and Safe, S. (2012) Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA27a:ZBTB10 in breast cancer. Mol. Cancer Ther. 11, 1421-1431
30. Loboda, A., Jazwa, A., Grochot-Przeczek, A., Rutkowski, A. J., Cisowski, J., Agarwal, A., Jozkowicz, A. and Dulak, J. (2008) Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 10, 1767-1812.
31. Mengoni, F., Lichtner, M., Battinelli, L., Marzi, M., Mastroianni, C. M., Vullo, V. and Mazzanti, G. (2002) In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells. Planta Med. 68, 111-114.
32. Mu, X., Shi, W., Sun, L., Li, H., Jiang, Z. and Zhang, L. (2012) Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation. Molecules 17, 6854-6868.
33. Najid, A., Simon, A., Cook, J., Chable-Rabinovitch, H., Delage, C., Chulia, A. J. and Rigaud, M. (1992) Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett. 299, 213-217.
34. Neymotin, A., Calingasan, N. Y., Wille, E., Naseri, N., Petri, S., Damiano, M., Liby, K. T., Risingsong, R., Sporn, M., Beal, M. F. and Kiaei, M. (2011) Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 51, 88-96.
35. Nichols, D. P., Ziady, A. G., Shank, S. L., Eastman, J. F. and Davis, P. B. (2009) The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L828-836.
36. Petronelli, A., Pannitteri, G. and Testa, U. (2009) Triterpenoids as new promising anticancer drugs. Anticancer Drugs 20, 880-892.
37. Phillips, D. R., Rasbery, J. M., Bartel, B. and Matsuda, S. P. (2006) Biosynthetic diversity in plant triterpene cyclization. Curr. Opin. Plant Biol. 9, 305-314.
38. Pi, J., Bai, Y., Reece, J. M., Williams, J., Liu, D., Freeman, M. L., Fahl, W. E., Shugar, D., Liu, J., Qu, W., Collins, S. and Waalkes, M. P. (2007) Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 42, 1797-1806.
39. Pitha-Rowe, I., Liby, K., Royce, D. and Sporn, M. (2009) Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN. Invest. Ophthalmol. Vis. Sci. 50, 5339-5347.
40. Reisman, S. A., Aleksunes, L. M. and Klaassen, C. D. (2009) Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochem. Pharmacol. 77, 1273-1282.
41. Shin, S., Wakabayashi, J., Yates, M. S., Wakabayashi, N., Dolan, P. M., Aja, S., Liby, K. T., Sporn, M. B., Yamamoto, M. and Kensler, T. W. (2009) Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur. J. Pharmacol. 620, 138-144.
42. Singh, G. B., Singh, S., Bani, S., Gupta, B. D. and Banerjee, S. K. (1992) Anti-inflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol. 44, 456-458.
43. Speranza, G., Gutierrez, M. E., Kummar, S., Strong, J. M., Parker, R. J., Collins, J., Yu, Y., Cao, L., Murgo, A. J., Doroshow, J. H. and Chen, A. (2012) Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors. Cancer Chemother. Pharmacol. 69, 431-438.
44. Sporn, M. B., Liby, K. T., Yore, M. M., Fu, L., Lopchuk, J. M. and Gribble, G. W. (2011) New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J. Nat. Prod. 74, 537-545.
45. Stack, C., Ho, D., Wille, E., Calingasan, N. Y., Williams, C., Liby, K., Sporn, M., Dumont, M. and Beal, M. F. (2010) Triterpenoids CDDOethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radic. Biol. Med. 49, 147-158.
46. Suh, N., Honda, T., Finlay, H. J., Barchowsky, A., Williams, C., Benoit, N. E., Xie, Q. W., Nathan, C., Gribble, G. W. and Sporn, M. B. (1998) Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 58, 717-723.
47. Sykiotis, G. P. and Bohmann, D. (2010) Stress-activated cap'n'collar transcription factors in aging and human disease. Sci. Signal. 3, re3.
48. Takagi, K., Park, E. H. and Kato, H. (1980) Anti-inflammatory activities of hederagenin and crude saponin isolated from Sapindus mukorossi Gaertn. Chem. Pharm. Bull. (Tokyo) 28, 1183-1188.
49. Tokuda, H., Ohigashi, H., Koshimizu, K. and Ito, Y. (1986) Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett. 33, 279-285.
50. Vannini, N., Lorusso, G., Cammarota, R., Barberis, M., Noonan, D. M., Sporn, M. B. and Albini, A. (2007) The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent. Mol. Cancer Ther. 6, 3139-3146.
51. Was, H., Dulak, J. and Jozkowicz, A. (2010) Heme oxygenase-1 in tumor biology and therapy. Curr. Drug Targets 11, 1551-1570.
52. Wei, Y., Gong, J., Yoshida, T., Eberhart, C. G., Xu, Z., Kombairaju, P., Sporn, M. B., Handa, J. T. and Duh, E. J. (2011) Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. Free Radic. Biol. Med. 51, 216-224.
53. Yore, M. M., Liby, K. T., Honda, T., Gribble, G. W. and Sporn, M. B. (2006) The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta. Mol. Cancer. Ther. 5, 3232-3239.
54. Yoshimi, N., Wang, A., Morishita, Y., Tanaka, T., Sugie, S., Kawai, K., Yamahara, J. and Mori, H. (1992) Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn. J. Cancer Res. 83, 1273-1278.
55. Yu, A. L., Lu, C. Y., Wang, T. S., Tsai, C. W., Liu, K. L., Cheng, Y. P., Chang, H. C., Lii, C. K. and Chen, H. W. (2010) Induction of heme oxygenase 1 and inhibition of tumor necrosis factor alpha-induced intercellular adhesion molecule expression by andrographolide in EA.hy926 cells. J. Agric. Food Chem. 58, 7641-7648.
56. Yu, X. and Kensler, T. (2005) Nrf2 as a target for cancer chemoprevention. Mutat. Res. 591, 93-102.
57. Yuk, J. E., Lee, M. Y., Kwon, O. K., Cai, X. F., Jang, H. Y., Oh, S. R., Lee, H. K. and Ahn, K. S. (2011) Effects of astilbic acid on airway hyperresponsiveness and inflammation in a mouse model of allergic asthma. Int. Immunopharmacol. 11, 266-273.
58. Zeng, X. Y., Wang, Y. P., Cantley, J., Iseli, T. J., Molero, J. C., Hegarty, B. D., Kraegen, E. W., Ye, Y. and Ye, J. M. (2012) Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1 induced suppression of hepatic gluconeogenesis in type-2 diabetic mice. PLoS One 7, e42115.